Skip to main content
OpenTrials
Completed

NCT Number: NCT02440113

Post-operative CT Follow up After Nellix Endoprosthesis Implantation

Multicenter retrospective CT follow up after aortic aneurysm repair using Nellix Endoprosthesis.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Rationale:

In patients with abdominal aortic aneurysms the Nellix Endoprosthesis aims to reduce post-operative complications and subsequent re-intervention rates. Using two stents covered with two polymer filled endobags used for sealing and excluding the aneurysm sac. Preliminary results show promising results in reducing these complications. The new endoprosthesis is not only different in treatment but also in follow up imaging. To date it is unknown how the stent, polymer filled endobags and aneurysm appear in CT imaging in short and long term follow up.

Objective:

To assess and describe the normal computed tomography (CT) appearance at 30 days and 1 year after implantation of the Nellix Endoprosthesis.

Study population:

Approximately a total of 100 patients who underwent endovascular aneurysm repair using Nellix endoprosthesis in three different hospitals. The population is comprised of approximately fifty patients from Rijnstate Ziekenhuis Arnhem and twenty-five each from St. Antonius Nieuwegein and St. Elisabeth Tilburg.

Design and methods:

The study is designed as a multicenter retrospective cohort. Using CT-scans from regular follow up dates (30 days and 1 year) imaging will be retrospectively assessed using medical imaging software. Main study endpoints are defined as followed:

  • Changes in the infrarenal neck morphology (below the renal arteries)
  • Changes in the thrombus in the aneurysm sac
  • Changes in the aneurysm wall and geometry
  • Changes in the cobalt-chromium stent and their lumen
  • Changes in the polymer-filled endobags Using anonymous patient data a database will be created an securely stored. Patient consent for study participation will be attained before accessing patient files.

Nature and extent of the burden and risk associated with participation, benefit and group relatedness:

The study will not bring an extra burden or risk for patients participating. Patients are encouraged to participate to improve insight for patients with the same disease and might improve health care in the future for this group of patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who underwent endovascular abdominal aneurysm repair using the Nellix endoprosthesis

Exclusion criteria

  • No specific exclusion criteria

Treatment and study plan

Nellix

Device

Nellix Implantation

Primary outcomes

  1. Changes in the infrarenal neck morphology (below the renal arteries)

    Time frame: 1 year

  2. Changes in the thrombus in the aneurysm sac

    Time frame: 1 year

  3. Changes in the aneurysm wall and geometry

    Time frame: 1 year

  4. Changes in the cobalt-chromium stent and their lumen

    Time frame: 1 year

  5. Changes in the polymer-filled endobags Using anonymous patient data a database will be created an securely stored. Patient consent for study participation will be attained before accessing patient files

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Rijnstate Hospital

Other

Registry information

Official study title

Post-operative CT Follow up Measurement After Nellix Endoprosthesis Implantation in Patients With Abdominal Aortic Aneurysms.

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
May 12, 2015
Registry last updated
Jul 15, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.